DATASHEET: Opto® Plasma B Discovery 4.0 Workflow
Key Highlights
- Recovery of 1,000s of hits from over 40,000 individual plasma B cells in a single 4-chip workflow
- Down-selection of lead candidates by functional profiling
- Sequencing and re-expression of >1,000 functionally-characterized antibodies
Related Resources
View All ResourcesApp Note: Discover Lead Molecules Against Difficult Targets Inaccessible by Hybridoma Methods
Download this application note to learn about how the Opto™ Plasma B Discovery workflow increases hit recovery for difficult membrane-bound targets and provides access to greater sequence diversity when compared to traditional hybridoma methods.
POSTER: High-throughput Cell-free Protein Expression Coupled with Functional Characterization
Authored by Qiong Gao, et al., and presented at SLAS 2023
Application Note: Rapid Discovery of Therapeutic Antibodies for the SARS-CoV-2 Pandemic Virus Using the Opto Viral Neutralization 1.0 Workflow
Learn how to use blocking and binding assays and the Opto Viral Neutralization 1.0 workflow to identify cross-reactive antibodies that may have broad neutralization capacity across the coronavirus family.